Skip to main content

Isabelle Guyon

Premium

Health Discovery Corp. (formerly Direct Wireless Communications) last week appointed Isabelle Guyon, a former neural network specialist at AT&T Bell Laboratories, to its scientific advisory board. Guyon, an expert in statistical data analysis, pattern recognition, and machine learning, is vice president of the International Unipen Foundation, which oversees a large-scale database of handwritten samples for use in handwriting recognition research. Through her consulting firm Clopinet, Guyon has developed data analysis methods for genomics and proteomics applications in biomarker discovery, among other projects.

Filed under

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.